Abstract
In order to maintain a competitive advantage, occupy a leadership position on the market and take on the role of a creator of the "rules of the game", high-tech companies rely on their innovation activity, and invest significantly in research and development (R&D) activity, the output of which are inventions that are the potential subject of patent protection. The company's patent activity is an indicator of its innovation activity and an instrument that the company can use to achieve various business goals. The goal of this research is to determine the impact that research and development activities have on patent activity of high-tech companies that are on WIPO's Top 50 PCT applicants list from 2013 to 2020. Using a panel regression analysis, it was established that investments in research and development have a positive impact on the company's patent activity expressed by the number of granted patents and the number of published PCT applications. Also, it was determined that the return on investment in research and development has a positive impact on the number of granted patents, but a negative impact on the number of published PCT applications. Finally, no statistically significant impact of research and development intensity on patent activity indicators was found.
Funder
Ministry of Education, Science and Technological Development of the Republic of Serbia
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference21 articles.
1. Ahuja, G. & Katila, R. (2001). Technological Acquisition and the Innovative Performance of Acquiring Firms: A Longitudinal Study. Strategic Management Journal, 22(3), 197-220;
2. Bilbao-Osorio, B., & Rodríguez-Pose, A. (2004). From R&D to innovation and economic growth in the EU. Growth and Change, 35(4), 434-455;
3. Bound, J., Cummins, C., Griliches, Z., Hall, B.H., & Jaffe, A. (1984). Who Does R&D and Who Patents? In: Griliches, Z. (Eds.), Patents and Productivity (pp. 21-54). Chicago: University of Chicago Press;
4. Cardinal, L.B., & Hatfield, D.E. (2000). Internal Knowledge Generation: The Research Laboratory and Innovative Productivity in the Pharmaceutical Industry. Journal of Engineering & Technology Management, 17(3-4), 247-271;
5. Christensen, C.M., & van Bever, D. (2014). The Capitalists Dilemma. Harvard Business Review, 92, 60-68;